DV
Dividend Vision

PRME — Prime Medicine, Inc. Common Stock

Prime Medicine, Inc. Common Stock (PRME)

Total return is -79.9% over the past 3.8 years, 203.1 points behind SPY at 123.2%. Its deepest 1-year drawdown was 59.5%.

This appears to be common stock in Prime Medicine, Inc., a single-stock holding rather than a diversified ETF. The fund type and structure suggest it holds equity in a single company with no specified dividend distribution rate or expense ratio data available. This holding profile is more suitable for investors seeking direct company exposure rather than those focused on regular dividend income or diversified dividend strategies.

PRME key facts

Asset type
Stock
Asset class
Equity
Inception date
10/20/2022
Last close
$3.09
Market cap
$550,883,264
Average volume
1571000.0
Beta
2.269
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.19